Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report

BACKGROUND: Both programmed cell death-1 (PD-1) inhibitors and lenvatinib, which have a synergistic effect, are promising drugs for tumor treatment. It is generally believed that combination therapy with a PD-1 inhibitor and lenvatinib is safe and effective. However, we report a case of toxic epider...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Kai-Kai, Han, Shan-Shan, He, Li-Ya, Yang, Lin-Lin, Liang, Bao-Ying, Zhen, Qing-Yu, Zhu, Zi-Bo, Zhang, Cai-Yun, Li, Hong-Yi, Lin, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048562/
https://www.ncbi.nlm.nih.gov/pubmed/35611193
http://dx.doi.org/10.12998/wjcc.v10.i11.3478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048562/
https://www.ncbi.nlm.nih.gov/pubmed/35611193
http://dx.doi.org/10.12998/wjcc.v10.i11.3478

Ejemplares similares